Is Glucosamine Joint Function Randomized Trial safe?

The current Migaku evidence database contains 2 reusable source documents for Glucosamine Joint Function Randomized Trial. This answer focuses on safety, limits, and clinician-discussion contexts. - This umbrella review synthesized evidence from published systematic reviews and meta-analyses on the effectiveness and safety of glucosamine in knee OA. [Li Y (2026); evidence level 3] - Glucosamine was associated with significant slowing of JSN progression (SMD - 0.32, p = 0.01), though this signal derived mainly from long-duration sulfate trials. [Li Y (2026); evidence level 3] - Conclusion Glucosamine demonstrated at most minimal-to-modest efficacy for knee OA, yielding a small pain reduction and possible slowing of radiographic progression but no clear functional benefit, with effects at or below the threshold of clinical importance. [Li Y (2026); evidence level 3] - Background Knee osteoarthritis (OA) is a common cause of pain and disability without a cure. [Li Y (2026); evidence level 3] - Background Osteoporosis (OP) associated with knee osteoarthritis (KOA) is common in older men and postmenopausal women, and it is important to find reliable and effective treatments for this disease to improve joint function and bone metabolism in this population. [Yang JJ (2022); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.